Symptomatic Cardiac Events in Patients with Lung Tumors Near The Heart Treated with Stereotactic Ablative Radiotherapy (SABR): A Single Institution Experience

被引：0

作者：

Ko, R. B. ^{[1
]}

Jani, K. ^{[2
]}

Sodji, Q. ^{[2
]}

Merriott, D. J. ^{[3
]}

Pickthorn, W. ^{[2
]}

Bush, K. ^{[1
]}

Maxim, P. G. ^{[4
]}

Diehn, M. ^{[5
]}

Loo, B. W., Jr. ^{[1
]}

机构：

[1] Stanford Canc Inst, Dept Radiat Oncol, Stanford, CA USA

[2] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA

[3] UC Irvine, Sch Med, Irvine, CA USA

[4] Stanford Canc Inst, Dept Radiat Oncol, Indianapolis, IN USA

[5] Dept Radiat Oncol, Stanford, CA USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期

关键词：

D O I：

10.1016/j.ijrobp.2019.06.151

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1071

引用

页码：S148 / S148

页数：1

共 50 条

[1] Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic Gynecologic Malignancies: A Single Institution Experience
Cuttino, L. W.
Evans, J. E.
Snyder, W. J.
Ford, T. C.
Egloff, S. Arnold
Boardman, C. H.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E266 - E266
[2] Stereotactic Ablative Radiotherapy (SABR) for Prostate Cancer - an Analysis of 500 Consecutive Patients Treated at a Single Institution
Miszczyk, L.
Namysl-Kaletka, A. J.
Napieralska, A.
Kraszkiewicz, M.
Miszczyk, M.
Wozniak, G.
Stapor-Fudzinska, M.
Glowacki, G.
Tukiendorf, A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E295 - E295
[3] Identifying dosimetric predictors of toxicity in multiple lung tumors treated with stereotactic ablative radiotherapy (SABR)
Tekatli, H.
Tetar, S.
Warner, A.
Palma, D.
Verbakel, W.
Nguyen, T.
Spoelstra, F.
Gaede, S.
Slotman, B.
Senan, S.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S143 - S143
[4] Radiomics for Early Detection of Recurrence in Patients Treated with Lung Stereotactic Ablative Radiotherapy (SABR)
Kunkyab, T.
Mou, B.
Jirasek, A.
Haston, C.
Andrews, J.
Thomas, S.
Hyde, D.
MEDICAL PHYSICS, 2020, 47 (06) : E436 - E436
[5] Spatial Assessment of Dose Distributions for Patients with Lung Cancer Treated with Stereotactic Ablative Radiotherapy (SABR)
Liu, D.
Chen, D.
Chetvertkov, M.
Altman, M.
Li, H.
Wen, N.
Glide-Hurst, C.
Ajlouni, M.
Levin, K.
Movsas, B.
Chetty, I.
MEDICAL PHYSICS, 2012, 39 (06) : 3817 - 3817
[6] EARLY DETECTION OF RECURRENCE IN PATIENTS TREATED WITH LUNG STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) USING RADIOMICS
Kunkyab, Tenzin
Mou, Benjamin
Jirasek, Andrew
Haston, Christina
Andrews, Jeffrey
Thomas, Steven
Hyde, Derek
RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S31 - S31
[7] Central Lung Tumors Eligible for Stereotactic Ablative Radiotherapy (SABR) Trials: Analysis of a Cohort Treated Using MR-Guided SABR
Giraud, N.
Schneiders, F. L.
Palacios, M. A.
de Koste, J. R. van Sornsen
Sesan, S.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E20 - E20
[8] Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors
Chaudhuri, Aadel A.
Tang, Chad
Binkley, Michael S.
Jin, Michelle
Wynne, Jacob F.
von Eyben, Rie
Hara, Wendy Y.
Trakul, Nicholas
Loo, Billy W., Jr.
Diehn, Maximilian
LUNG CANCER, 2015, 89 (01) : 50 - 56
[9] Toxicities and Survival after Stereotactic Ablative Radiotherapy (SABR) for Centrally Located Lung Tumors
Atalar, B.
Mustafayev, T.
Sio, T.
Sahin, B.
Gungor, G.
Aydin, G.
Yapici, B.
Ozyar, E.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S836 - S837
[10] Safety and Efficacy of Stereotactic Ablative Radiotherapy (SABR) to Multiple (3 or More) Lung Tumors
Moding, E. J.
Maxim, P. G.
Diehn, M.
Loo, B. W., Jr.
Gensheimer, M. F.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E482 - E482

← 1 2 3 4 5 →